Supplementary Figure S2 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models | Synapse
June 5, 2024Open Access
Supplementary Figure S2 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Tolerability for the Combination of Eribulin and Copanlisib